Nobuyuki Hinata received his M.D. from Kobe University in 1998, and his Ph.D. in Medicine from Kobe University Graduate School of Medicine in 2004. After completing clinical and academic training in urology at multiple institutions including Tottori University, Kobe University Hospital, and Roswell Park Comprehensive Cancer Center (Urology), he joined Hiroshima University as a Professor in the Graduate School of Biomedical and Health Sciences (Medical Sciences) in October 2021. He is engaged in both clinical care and research in urological oncology and reconstructive urology, with a focus on robot-assisted surgical techniques, genitourinary cancer management, and translational research aimed at improving outcomes for patients with prostate, bladder, and renal cancers through genomic profiling, therapeutic optimization, and multidisciplinary treatment strategies.
Nobuyuki Hinata received his M.D. from Kobe University in 1998, and his Ph.D. in Medicine from Kobe University Graduate School of Medicine in 2004. After completing clinical and academic training in urology at multiple institutions including Tottori University, Kobe University Hospital, and Roswell Park Comprehensive Cancer Center (Urology), he joined Hiroshima University as a Professor in the Graduate School of Biomedical and Health Sciences (Medical Sciences) in October 2021. He is engaged in both clinical care and research in urological oncology and reconstructive urology, with a focus on robot-assisted surgical techniques, genitourinary cancer management, and translational research aimed at improving outcomes for patients with prostate, bladder, and renal cancers through genomic profiling, therapeutic optimization, and multidisciplinary treatment strategies.